Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts

MeSH terms

• Adult
• Biomarkers
• Bone Marrow Transplantation / adverse effects*
• Cell Line
• Child
• Clinical Protocols
• Cytotoxicity, Immunologic
• Drug Resistance / genetics
• Female
• Genetic Vectors
• Graft vs Host Disease / prevention & control
• Herpesviridae Infections / prevention & control*
• Herpesviridae Infections / transmission
• Herpesvirus 4, Human* / growth & development
• Herpesvirus 4, Human* / immunology
• Humans
• Immunocompromised Host
• Incidence
• Informed Consent
• Kanamycin Kinase
• Leukemia / surgery
• Lymphoma, Non-Hodgkin / surgery
• Lymphoproliferative Disorders / epidemiology
• Lymphoproliferative Disorders / microbiology
• Lymphoproliferative Disorders / prevention & control*
• Male
• Moloney murine leukemia virus / genetics
• Myelodysplastic Syndromes / surgery
• Neomycin / pharmacology
• Phosphotransferases (Alcohol Group Acceptor) / biosynthesis
• Phosphotransferases (Alcohol Group Acceptor) / genetics*
• Recombinant Fusion Proteins / biosynthesis
• Recombinant Fusion Proteins / genetics*
• Safety
• T-Lymphocytes, Cytotoxic / drug effects
• T-Lymphocytes, Cytotoxic / immunology
• T-Lymphocytes, Cytotoxic / transplantation*
• Tissue Donors
• Transplantation, Homologous
• Tumor Virus Infections / prevention & control*
• Tumor Virus Infections / transmission
• Virus Activation* / immunology